LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44
ANNÉE
2024
AUTEURS
Lambert A, Bouche O, Ayav A, Bachet JB, Schwarz L, Piessen G, Vendrely V, Laurent V, Thibaudeau E, Miglianico L, Rinaldi Y, Hammel P, Conroy T
CONGRÈS/REVUE
ESMO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES